FDA slammed for perpetuating “confusion and gray area” in CBD supplement regulation

The US food and drug agency holds its ground that risks run too high to allow the ingredient to be openly marketed

Related Articles

Woman waking refreshed.

NUTRITION & HEALTH NEWS

29 May 2024 --- A clinical trial reveals that Monteloeder’s RelaxPLX supplement improves sleep patterns and increases endogenous secretion of melatonin, the... Read More

Supplements in different capsule forms.

NUTRITION & HEALTH NEWS

29 May 2024 --- Researchers from various academic institutions in the US, China, Denmark and the UK conducted a large long-term cohort study into the regular use of fish... Read More

Prickly pear cladodes and fruits.

NEW PRODUCT DEVELOPMENT

23 May 2024 --- Bionap adds Odilia to its range of standardized botanical extracts of fruits and plants from the Mediterranean region. The powdered extract of the... Read More

The Steenvoorde production facility

NUTRITION & HEALTH NEWS

23 May 2024 --- Danone has invested €70 million (US$76 million) in its Steenvoorde production facility in France to bolster its specialized nutrition category... Read More

Women of two generations eating lunch.

NUTRITION & HEALTH NEWS

22 May 2024 --- At this year’s Vitafoods Europe, women’s health was a key topic, with leading brands showcasing their nutraceutical solutions for the growing... Read More

trans